NBTY's Julian Graves acquisition clears
This article was originally published in The Tan Sheet
Executive Summary
U.K. regulators July 22 clear supplement firm NBTY's acquisition of 350-store U.K. confectionery chain Julian Graves. The OK followed provisional findings by the Competition Commission, the Ronkonkoma, N.Y.-based firm said. The firm purchased Julian Graves in September for $25 million, but the commission raised concerns the acquisition could obstruct competition in the market for seeds, nuts and dried fruit (1"The Tan Sheet" July 20, 2009). NBTY said it expects the commission to make a final decision before Sept. 4
You may also be interested in...
NBTY Not "Trigger Happy," But Acquisitions Stay In Its Crosshairs
NBTY hopes to remain a supplement industry giant in part by continuing to acquire other businesses, a strategy with an improving outlook as opportunities emerge during the global economic slump
Takeda, Astellas Found New JV To Support Japanese Bioventures
Major Japanese companies Takeda, Astellas and SMBC are joining hands to establish a new joint venture with $3.9m capital and based in Japan’s largest biocluster Shonan iPark to help incubate local biopharma start-ups.
Could Eledon’s Anti-CD40L Change Transplant Medicine?
Eledon Pharmaceuticals’ CD40 Ligand blocker has yielded impressive results for post-transplant immunosuppression and cutting-edge transplant doctors have also used it for pig-to-human kidney and heart transplants, opening up the field of xenotransplantation.